Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Jericho the lion, who it had been claimed was shot dead yesterday by poachers in Zimbabwe, is "alive and well", conservationists have said.
A hitchhiking robot that won the hearts of fans worldwide has met an untimely end after being vandalised on its trip across the US.
Rules could be changed to remove support for failed asylum seekers living in Britain with their families, a Home Office minister has said.